Viewing Study NCT01644968


Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2025-12-26 @ 10:12 PM
Study NCT ID: NCT01644968
Status: COMPLETED
Last Update Posted: 2022-05-17
First Post: 2012-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer
Sponsor: Providence Health & Services
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module